Signifor (Pasireotide Injection) and QT prolongation
Result of checking the interaction of drug Signifor (Pasireotide Injection) and disease QT prolongation for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of pasireotide is associated with QT prolongation. Pasireotide should be used with caution in patients who are at significant risk of developing QT prolongation. It is recommended to correct levels of hypokalemia and hypomagnesemia prior to starting therapy with this agent. Assess ECG at the beginning of therapy and monitor during therapy. Care should be taken in predisposed patients.
Generic Name: pasireotide
Brand Name: Signifor, Signifor LAR
Synonyms: Signifor, Signifor Injection